HYPERTROPHIC CARDIOMYOPATHY (HCM)
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY (HCM) explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY (HCM) trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug mavacamten shows promise in Real-World HCM patients
Disease control CompletedThis study tested the drug mavacamten in 222 adults with a type of heart disease called obstructive hypertrophic cardiomyopathy (oHCM), which makes the heart muscle thick and blocks blood flow. Researchers compared patients who got mavacamten to those on standard treatment, measu…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated May 26, 2026 11:42 UTC
-
New heart drug shows promise in thick heart muscle trial
Disease control CompletedThis study tested a new drug called CK-3773274 (aficamten) in 96 adults with symptomatic hypertrophic cardiomyopathy, a condition where the heart muscle is abnormally thick. The goal was to find the best dose that is safe and improves heart function. Participants received either …
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY (HCM)
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC